FDA Clears New Oral Therapy for Advanced Breast Cancer
Federal regulators have approved giredestrant paired with everolimus for specific types of advanced breast cancer following positive clinical trial data.
🧠Mind & Mental HealthPhoto: medpagetoday.com
Key points
- FDA approved giredestrant combined with everolimus for advanced breast cancer
- Phase III trial showed median progression-free survival nearly doubled in patients with ESR1 mutations
- Companion diagnostic assay authorized to identify eligible patients with specific genetic profiles
The U.S. Food and Drug Administration has granted approval to giredestrant, marketed as Wilserdly, to be used alongside everolimus for treating adults with estrogen receptor-positive, HER2-negative, ESR1-mutated breast cancer that has progressed despite prior therapies. This all-oral treatment regimen is specifically indicated for individuals facing locally advanced or metastatic disease who experienced recurrence during or after endocrine adjuvant therapy, or following at least one previous endocrine regimen in a metastatic setting.
Approval stems from the global phase III evERA trial, which contrasted the giredestrant combination against standard endocrine therapy paired with everolimus. Data from participants with ESR1-mutated cancer revealed that median progression-free survival expanded significantly from 5.5 months under standard care to 10.0 months using the new combination. For the broader trial cohort, median progression-free survival reached 8.8 months with the giredestrant regimen.
Potential Side Effects and Safety Warnings
Commonly observed adverse events tied to the regimen included stomatitis, fatigue, rash, diarrhea, musculoskeletal pain, nausea, and pneumonitis. Additionally, frequent laboratory abnormalities involved decreases in hemoglobin, lymphocytes, white blood cells, neutrophils, platelets, calcium, potassium, and sodium, alongside elevated levels of aspartate transaminase, alanine transaminase, and creatinine. The official prescribing information also highlights specific warnings regarding embryo-fetal toxicity and bradycardia.
Alongside the drug approval, the agency cleared the FoundationOne Liquid CDx assay to serve as a companion diagnostic tool for detecting ESR1 mutations in breast cancer patients. What to know: While clinical trials suggest improved disease control, patients should consult their healthcare providers to evaluate personal treatment risks and benefits.
As oncologists we are always looking for better and more effective treatments for patients with metastatic breast cancer, particularly when their disease progresses on endocrine therapies and CDK4/6 inhibitors. - Dr. Erica Mayer, Dana-Farber Cancer Institute
Source medpagetoday.com — medpagetoday.com/hematologyoncology/breastcancer/123915 ↗
Read next
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🏥Public HealthRecall Issued for Generic Propranolol Over Potential Metal Contamination
Breckenridge Pharmaceutical has initiated a voluntary recall of one lot of generic propranolol capsules due to the potential presence of metal fragments.
🥗NutritionUnderstanding Food Science: Why Some Leftovers Freeze Better Than Others
Freezing leftovers is an effective way to minimize food waste, though the success of the process depends on the cellular structure and composition of the food being store…